Has Richard Lucariello, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,222 in general payments to Richard Lucariello, MD across 241 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Lucariello, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Lucariello, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Lucariello, MD

MOHS-Micrographic Surgery · Myrtle Beach, SCNPI 1164953378

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.0% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations.

$5,222in general payments, 2019–2025

Across 241 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$803
AbbVie$715
Sanofi$669
Johnson & Johnson$585
Sun Pharmaceutical Industries Inc.$428
Novartis$406
plus $2K from 16 others

What the payments were for

Food & beverage$4,85593%
Education$3677%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	22	$803
AbbVie	40	$715
Sanofi	28	$669
Johnson & Johnson	32	$585
Sun Pharmaceutical Industries Inc.	15	$428
Novartis	20	$406
Amgen	11	$292
UCB, Inc.	11	$256
Dermavant Sciences, Inc.	20	$239
Pfizer	10	$161
Incyte Corporation	6	$146
LEO Pharma Inc.	6	$129
Organogenesis Inc.	3	$77
Arcutis Biotherapeutics, Inc.	4	$75
E.r. Squibb & Sons, L.L.C.	3	$61
Lilly USA, LLC	3	$45
Biofrontera Inc.	2	$39
Tempus AI, Inc	1	$24
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$22
Smith+Nephew	1	$21
Botanix SB Inc	1	$16
Strata Skin Sciences, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LIBTAYO$238

How this compares

$5,222 in reported general payments places this provider in the 60th percentile of 22 mohs-micrographic surgery providers in South Carolina.

See all mohs-micrographic surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$811,996

Medicare patients

1,423

Services billed

5,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	247	$15,924
Triamcinolone Acetonide	230	$4,166
Ketoconazole	165	$2,649
Hydrocortisone	168	$1,943
Tretinoin	24	$1,863
Mometasone Furoate	105	$1,806
Clindamycin Phosphate	58	$1,637
Metronidazole	28	$1,339
Mupirocin	78	$675
Doxycycline Hyclate	59	$638
Doxycycline Monohydrate	29	$325
Clindamycin Hcl	19	$280
Cephalexin	43	$204
ValacyclovirValacyclovir Hcl	18	$133
Amoxicillin	16	$27

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Myrtle Beach

Brandon CoakleyMyrtle Beach$24K
Brent FolsomMyrtle Beach$3K
Fabrizio GalimbertiConway$765K
Yumeng LiConway$33K
Joseph McGowanBluffton$10K
Bradley SaylorsNorth Charleston$8K
Ruth McTigheMt Pleasant$7K
Taylor MulkeyMt Pleasant$7K
Julie JeffersonGreenville$5K
Oswald MikellHilton Head Island$5K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →